GWM
VSTM icon

Geneos Wealth Management’s Verastem VSTM Stock Holding History

Geneos Wealth Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25
Closed -$1K – 2912
2021
Q2 		$1K Buy
+25
New +$1.04K ﹤0.01% 2809
2020
Q4 		– Sell
-108
Closed -$1K – 3012
2020
Q3 		$1K Hold
108
– – ﹤0.01% 2583
2020
Q2 		$2K Hold
108
– – ﹤0.01% 2395
2020
Q1 		$3K Hold
108
– – ﹤0.01% 2216
2019
Q4 		$1K Hold
108
– – ﹤0.01% 2512
2019
Q3 		$1K Hold
108
– – ﹤0.01% 2447
2019
Q2 		$1K Hold
108
– – ﹤0.01% 2450
2019
Q1 		$3K Hold
108
– – ﹤0.01% 2189
2018
Q4 		$4K Hold
108
– – ﹤0.01% 2077
2018
Q3 		$9K Buy
108
+83
+332% +$8.25K ﹤0.01% 1893
2018
Q2 		$2K Buy
+25
New +$1.53K ﹤0.01% 2139

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Geneos Wealth Management's VSTM Position: Q3 2021 in Review

Geneos Wealth Management sold out of Verastem (VSTM) in Q3 2021, closing a stake of 25 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in VSTM in Q2 2018 and held it in 11 quarters. The position peaked at $9K in Q3 2018. 147 funds tracked by Wall St. Rank hold VSTM as of Q3 2021.

  • Geneos Wealth Management reported no remaining Verastem position as of Q3 2021 after selling out during the quarter.
  • Geneos Wealth Management sold 25 Verastem shares in Q3 2021, an estimated $1K.
  • Geneos Wealth Management first reported a position in Verastem in Q2 2018 and held it in 11 quarters.
  • Geneos Wealth Management's Verastem position peaked at $9K in Q3 2018.
  • 147 funds tracked by Wall St. Rank held Verastem as of Q3 2021.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.